Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
477K
-
Shares change
-
+477K
-
Total reported value, excl. options
-
$2.4M
-
Value change
-
+$2.4M
-
Number of buys
-
21
-
Price
-
$5.03
Significant Holders of Lipocine Inc. - COM NEW (LPCN) as of Q2 2023
22 filings reported holding LPCN - Lipocine Inc. - COM NEW as of Q2 2023.
Lipocine Inc. - COM NEW (LPCN) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 477K shares
.
Largest 10 shareholders include VANGUARD GROUP INC (221K shares), BlackRock Inc. (80.3K shares), GEODE CAPITAL MANAGEMENT, LLC (48.8K shares), WEALTH EFFECTS LLC (29.3K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (24.7K shares), STATE STREET CORP (18.6K shares), Kestra Advisory Services, LLC (16.7K shares), TWO SIGMA INVESTMENTS, LP (11K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (11K shares), and RENAISSANCE TECHNOLOGIES LLC (10.4K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.